Phase II study of dasatinib (DA) in combination with chemotherapy and allogeneic stem cell transplantation (SCT) for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia by Japan Acute Leukemia Study Group (JALSG Ph+ALL213)
Latest Information Update: 22 Jul 2021
At a glance
- Drugs Dasatinib (Primary) ; Antineoplastics; Prednisolone
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 25 Jun 2020 Status changed from active, no longer recruiting to completed.
- 06 Nov 2019 Results released at the 61st Annual Meeting and Exposition of the American Society of Hematology
- 28 Aug 2016 Status changed from recruiting to active, no longer recruiting.